Log in

M&AEconomic Times

Sun Pharma eyes $4B loan for Organon buy

Positive+62

GreyOak summary

Sun Pharma is arranging a $4 billion syndicated loan to refinance part of its $11.75 billion acquisition of US healthcare firm Organon. Five lead banks are finalizing terms for the facility, with additional lenders expected to join. The deal, approved by Organon shareholders, is anticipated to close in late 2026 or early 2027.

What it affects

Source

Read the original at Economic Times

More Sun Pharmaceutical Industries news

All Sun Pharmaceutical Industries news →